does novo nordisk have a patent on semaglutide HOLVES丨The for has expired Novo Nordisk and D Young

The injectable medications mimic a hormone made in the gut called glucagon-like peptide-1 (GLP-1), which helps manage blood sugar, reduce appetite and slow stomach emptying so you feel fuller, longer

367 The efficacy of once-weekly semaglutide (2.4 mg) or once-daily liraglutide (3 mg) on weight loss was compared in a 68-week, open-label, placebo-controlled clinical trial enrolling 338 overweight or obese individuals without type 2 diabetes

Semaglutide doesnt specifically target muscle or facial fat

If nausea is severe, talk to your healthcare provider for alternative options

Here's what to eat or avoid

Of course, its early and Phase 3 trials will tell us more, but the numbers so far are unprecedented in obesity pharmacotherapy